-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.00478.95% Upside
aTyr Pharma, Inc. Frequently Asked Questions
-
What analysts cover aTyr Pharma, Inc.?
aTyr Pharma, Inc. has been rated by research analysts at Piper Sandler in the past 90 days.